Gene expression profiling in blood from cerebral malaria patients and mild malaria patients living in Senegal.
Adolescent
Adult
Aged
Child
Child, Preschool
Cluster Analysis
Female
Glycogen Synthase Kinase 3 beta
/ genetics
Humans
Infant
Malaria, Cerebral
/ blood
Male
Middle Aged
Protein Interaction Maps
/ genetics
Senegal
Severity of Illness Index
Signal Transduction
Transcription Factor RelA
/ genetics
Transcriptome
/ genetics
Young Adult
Cerebral malaria
Gene expression profiling
Mild malaria
Transcriptome
Journal
BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628
Informations de publication
Date de publication:
30 10 2019
30 10 2019
Historique:
received:
19
04
2019
accepted:
09
10
2019
entrez:
1
11
2019
pubmed:
2
11
2019
medline:
3
4
2020
Statut:
epublish
Résumé
Plasmodium falciparum malaria remains a major health problem in Africa. The mechanisms of pathogenesis are not fully understood. Transcriptomic studies may provide new insights into molecular pathways involved in the severe form of the disease. Blood transcriptional levels were assessed in patients with cerebral malaria, non-cerebral malaria, or mild malaria by using microarray technology to look for gene expression profiles associated with clinical status. Multi-way ANOVA was used to extract differentially expressed genes. Network and pathways analyses were used to detect enrichment for biological pathways. We identified a set of 443 genes that were differentially expressed in the three patient groups after applying a false discovery rate of 10%. Since the cerebral patients displayed a particular transcriptional pattern, we focused our analysis on the differences between cerebral malaria patients and mild malaria patients. We further found 842 differentially expressed genes after applying a false discovery rate of 10%. Unsupervised hierarchical clustering of cerebral malaria-informative genes led to clustering of the cerebral malaria patients. The support vector machine method allowed us to correctly classify five out of six cerebral malaria patients and six of six mild malaria patients. Furthermore, the products of the differentially expressed genes were mapped onto a human protein-protein network. This led to the identification of the proteins with the highest number of interactions, including GSK3B, RELA, and APP. The enrichment analysis of the gene functional annotation indicates that genes involved in immune signalling pathways play a role in the occurrence of cerebral malaria. These include BCR-, TCR-, TLR-, cytokine-, FcεRI-, and FCGR- signalling pathways and natural killer cell cytotoxicity pathways, which are involved in the activation of immune cells. In addition, our results revealed an enrichment of genes involved in Alzheimer's disease. In the present study, we examine a set of genes whose expression differed in cerebral malaria patients and mild malaria patients. Moreover, our results provide new insights into the potential effect of the dysregulation of gene expression in immune pathways. Host genetic variation may partly explain such alteration of gene expression. Further studies are required to investigate this in African populations.
Sections du résumé
BACKGROUND
Plasmodium falciparum malaria remains a major health problem in Africa. The mechanisms of pathogenesis are not fully understood. Transcriptomic studies may provide new insights into molecular pathways involved in the severe form of the disease.
METHODS
Blood transcriptional levels were assessed in patients with cerebral malaria, non-cerebral malaria, or mild malaria by using microarray technology to look for gene expression profiles associated with clinical status. Multi-way ANOVA was used to extract differentially expressed genes. Network and pathways analyses were used to detect enrichment for biological pathways.
RESULTS
We identified a set of 443 genes that were differentially expressed in the three patient groups after applying a false discovery rate of 10%. Since the cerebral patients displayed a particular transcriptional pattern, we focused our analysis on the differences between cerebral malaria patients and mild malaria patients. We further found 842 differentially expressed genes after applying a false discovery rate of 10%. Unsupervised hierarchical clustering of cerebral malaria-informative genes led to clustering of the cerebral malaria patients. The support vector machine method allowed us to correctly classify five out of six cerebral malaria patients and six of six mild malaria patients. Furthermore, the products of the differentially expressed genes were mapped onto a human protein-protein network. This led to the identification of the proteins with the highest number of interactions, including GSK3B, RELA, and APP. The enrichment analysis of the gene functional annotation indicates that genes involved in immune signalling pathways play a role in the occurrence of cerebral malaria. These include BCR-, TCR-, TLR-, cytokine-, FcεRI-, and FCGR- signalling pathways and natural killer cell cytotoxicity pathways, which are involved in the activation of immune cells. In addition, our results revealed an enrichment of genes involved in Alzheimer's disease.
CONCLUSIONS
In the present study, we examine a set of genes whose expression differed in cerebral malaria patients and mild malaria patients. Moreover, our results provide new insights into the potential effect of the dysregulation of gene expression in immune pathways. Host genetic variation may partly explain such alteration of gene expression. Further studies are required to investigate this in African populations.
Identifiants
pubmed: 31666081
doi: 10.1186/s12920-019-0599-z
pii: 10.1186/s12920-019-0599-z
pmc: PMC6821028
doi:
Substances chimiques
RELA protein, human
0
Transcription Factor RelA
0
GSK3B protein, human
EC 2.7.11.1
Glycogen Synthase Kinase 3 beta
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
148Références
PLoS Genet. 2013 May;9(5):e1003509
pubmed: 23717212
Trends Parasitol. 2010 Jan;26(1):11-5
pubmed: 19932638
PLoS Pathog. 2017 Mar 8;13(3):e1006267
pubmed: 28273147
Infect Immun. 2012 Mar;80(3):1150-5
pubmed: 22232187
Front Immunol. 2018 Sep 10;9:2016
pubmed: 30250468
Nature. 2012 Sep 20;489(7416):443-6
pubmed: 22895189
MBio. 2016 Feb 16;7(1):e01300-15
pubmed: 26884431
Nucleic Acids Res. 2013 Jan;41(Database issue):D1228-33
pubmed: 23180781
Semin Immunopathol. 2015 May;37(3):221-31
pubmed: 25772948
Front Immunol. 2017 Mar 09;8:212
pubmed: 28337195
Malar J. 2016 Mar 09;15:150
pubmed: 26961973
Nat Rev Immunol. 2005 Sep;5(9):722-35
pubmed: 16138104
J Infect Dis. 2017 Sep 15;216(6):771-775
pubmed: 28934429
Trends Parasitol. 2010 Jan;26(1):16-25
pubmed: 19914134
PLoS One. 2014 Dec 05;9(12):e114401
pubmed: 25479608
Nat Rev Genet. 2010 Feb;11(2):149-60
pubmed: 20084087
Front Mol Neurosci. 2017 Sep 15;10:294
pubmed: 28966576
Bioinformatics. 2002 Mar;18(3):490-1
pubmed: 11934752
Biotechniques. 2003 Feb;34(2):374-8
pubmed: 12613259
Trans R Soc Trop Med Hyg. 2000 Apr;94 Suppl 1:S1-90
pubmed: 11103309
J Immunol. 2003 Nov 15;171(10):5396-405
pubmed: 14607943
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W167-74
pubmed: 24861621
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16786-93
pubmed: 22949651
Trends Parasitol. 2012 Apr;28(4):151-60
pubmed: 22365903
PLoS Biol. 2018 Mar 12;16(3):e2004328
pubmed: 29529020
Front Cell Infect Microbiol. 2017 Jul 20;7:324
pubmed: 28775960
BMC Immunol. 2015 Mar 26;16:14
pubmed: 25887595
Clin Microbiol Rev. 2001 Oct;14(4):810-20, table of contents
pubmed: 11585786
BMC Genomics. 2007 Dec 06;8:452
pubmed: 18062806
Essays Biochem. 2019 Jul 3;63(2):217-225
pubmed: 31186287
Nat Biotechnol. 2010 May;28(5):495-501
pubmed: 20436461
Nat Genet. 2009 Jun;41(6):657-65
pubmed: 19465909
Biochim Biophys Acta. 2012 Jan;1822(1):49-56
pubmed: 21354307
PLoS Pathog. 2018 Oct 4;14(10):e1007298
pubmed: 30286211
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
PeerJ. 2018 Dec 3;6:e6048
pubmed: 30533319
J Infect Dis. 2011 Jan 15;203(2):211-9
pubmed: 21288821
PLoS Pathog. 2015 Jun 05;11(6):e1004963
pubmed: 26046849
Nat Med. 2013 Feb;19(2):168-78
pubmed: 23389617
J Infect Dis. 2019 Jan 1;219(1):154-164
pubmed: 30060095
Trends Parasitol. 2006 Nov;22(11):503-8
pubmed: 16979941
PLoS One. 2014 Feb 06;9(2):e86737
pubmed: 24516538
PLoS One. 2011;6(5):e19651
pubmed: 21603600
Infect Immun. 2011 Mar;79(3):1244-53
pubmed: 21149594
J Infect Dis. 2006 Jan 15;193(2):312-21
pubmed: 16362897
Trends Parasitol. 2010 Jun;26(6):277-8
pubmed: 20338809